Clinical outcomes of targeted therapies in elderly patients aged ≥ 80 years with metastatic colorectal cancer

BACKGROUND: The 5-fluorouracil-based chemotherapy combined with oxaliplatin or irinotecan is usually used in colorectal cancer (CRC). The addition of a targeted agent (TA) to this combination chemotherapy is currently the standard treatment for metastatic CRC. However, the efficacy and safety of com...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Hee Ryeong, Lee, Hui-Young, Song, Seo-Young, Lim, Kyu-Hyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561573/
https://www.ncbi.nlm.nih.gov/pubmed/36246797
http://dx.doi.org/10.12998/wjcc.v10.i28.10066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561573/
https://www.ncbi.nlm.nih.gov/pubmed/36246797
http://dx.doi.org/10.12998/wjcc.v10.i28.10066

Ejemplares similares